Avadel Pharmaceuticals PLC (AVDL) Stock Analysis

Avadel Pharmaceuticals PLC (AVDL) is a publicly traded company in the HEALTHCARE sector. It trades at $21.64. This page summarizes the public market data, fundamentals, and frequently asked questions for AVDL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $21.64

Market Sentiment

Avadel Pharmaceuticals PLC currently has a Neutral sentiment score of 0.07.

About Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals PLC is a Dublin-based biopharmaceutical company focused on developing innovative therapies for rare and complex conditions, particularly in sleep medicine and endocrine disorders. Leveraging its expertise in drug formulation and delivery, Avadel is committed to addressing significant unmet medical needs with its differentiated product pipeline. The company is well-positioned for growth in the dynamic biopharmaceutical landscape, actively pursuing strategic partnerships ...

GNG Research Analysis

GNG Research scores Avadel Pharmaceuticals PLC (AVDL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AVDL.

Frequently Asked Questions

Does AVDL pay dividends?

Avadel Pharmaceuticals PLC (AVDL) does not currently pay a regular dividend.